Mingming Zhu

Mingming Zhu is a Senior Advisor of Imaging R&D at Eli Lilly and Company, where they leverage extensive expertise in MR biophysics and brain research to support drug discovery and development. Previously, Mingming held roles as a Senior Research Scientist and Imaging Scientist at Eli Lilly, focusing on preclinical MRI projects related to various diseases, including oncology and neuroscience. Mingming also served as a Research Fellow at Memorial Sloan-Kettering Cancer Center and held multiple positions at Washington University School of Medicine, contributing to imaging research and education. Mingming earned a Ph.D. in Chemistry from Washington University in St. Louis and a B.S. in Chemistry from Nanjing University.